Search
Succinobucol
go.drugbank.com/drugs/DB05399InvestigationalAGI-1067, is a novel small molecule with anti-oxidant and anti-inflammatory properties that was discovered by AtheroGenics and designed to treat atherosclerosis of the blood vessels of the heart, or coronary
Alpha-galactosylceramide
go.drugbank.com/drugs/DB12232InvestigationalKRN7000 has been used in trials studying the treatment of Lung Cancer, Chronic Hepatitis C, Hepatitis B, Chronic, Unspecified Adult Solid Tumor, Protocol Specific, and Prevention of GvHD in Patients With
Naquotinib
go.drugbank.com/drugs/DB12036InvestigationalNaquotinib has been used in trials studying the treatment of Solid Tumors, Non-small Cell Lung Cancer, Non-Small-Cell Lung Cancer (NSCLC), Epidermal Growth Factor Receptor Mutations, and Epidermal Growth
S-3304
go.drugbank.com/drugs/DB12149InvestigationalS-3304 has been used in trials studying the treatment of Lung Cancer, Solid Tumors, Non Small Cell Lung Cancer, Stage IIIB Non Small Cell Lung Cancer, and Stage IIIA Non Small Cell Lung Cancer, among others
Reparixin
go.drugbank.com/drugs/DB12614InvestigationalReparixin has been used in trials studying the treatment and prevention of Breast Cancer, Metastatic Breast Cancer, Pancreatectomy for Chronic Pancreatitis, Islet Transplantation in Diabetes Mellitus Type
Onapristone
go.drugbank.com/drugs/DB12637InvestigationalOnapristone has been used in trials studying the treatment of Prostate Cancer, Recurrent Prostate Cancer, Metastatic Prostate Cancer, Androgen-independent Prostate Cancer, and Progesterone Receptor Positive
Viquidacin
go.drugbank.com/drugs/DB19549ExperimentalViquidacin has a monoisotopic molecular weight of 504.16 Da.
Barucainide
go.drugbank.com/drugs/DB19585ExperimentalBarucainide has a monoisotopic molecular weight of 354.23 Da.
Eptazocine
go.drugbank.com/drugs/DB19670ExperimentalEptazocine has a monoisotopic molecular weight of 231.16 Da.
Suricainide
go.drugbank.com/drugs/DB19705ExperimentalSuricainide has a monoisotopic molecular weight of 369.21 Da.